array(3) { ["company_details"]=> array(13) { ["name"]=> string(25) "Gsk Consumer Health, Inc." ["slug"]=> string(32) "4abba-us-gsk-consumer-health-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/8434ac9a-9bf2-4877-a3a0-a4039c237204" ["description"]=> string(518) "GSK Consumer Healthcare is a global business that discovers, develops, and manufactures innovative consumer healthcare products. It is an associate of GlaxoSmithKline plc, one of the world's largest healthcare companies. GSK Consumer Healthcare aims to become one of the world's most innovative, best performing, and trusted healthcare companies. Their goal is to improve lives through scientific innovation, build category-defining brands, and become Pakistan's first and best Fast Moving Consumer Healthcare Company." ["address_street"]=> string(28) "184 Liberty Corner Rd Ste 78" ["address_place"]=> string(6) "Warren" ["address_region"]=> string(10) "New Jersey" ["founding_date"]=> string(10) "1994-02-28" ["website_domain"]=> string(7) "gsk.com" ["website_url"]=> string(19) "https://www.gsk.com" ["industry_codes"]=> array(1) { [0]=> string(27) "Pharmaceutical Preparations" } ["employee_count"]=> int(300) ["article_count"]=> int(450) } ["articles"]=> array(7) { [0]=> array(7) { ["title_en"]=> string(109) "Business life - In La Chapelle-d'Angillon, 3C France benefits from investments in the pharmaceutical industry" ["snippet_en"]=> string(141) "In a booming pharmaceutical sector, the family business 3C France has won a big deal with the British giant GSK which is investing in France." ["url"]=> string(166) "https://www.leberry.fr/chapelle-d-angillon-18380/actualites/a-la-chapelle-d-angillon-3c-france-tire-profit-des-investissements-de-l-industrie-pharmaceutique_14463663/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/29509172-b68e-459c-9a0a-45833c78c838" ["source"]=> string(10) "leberry.fr" ["publication_date"]=> string(10) "2024-03-06" ["categories"]=> array(3) { [0]=> string(19) "Foreign Development" [1]=> string(18) "General Investment" [2]=> string(15) "Deals & Tenders" } } [1]=> array(7) { ["title_en"]=> string(36) "GSK wins CAM herpes vaccine contract" ["snippet_en"]=> string(271) "The pharmaceutical company GSK will be the sole supplier of the shingles vaccine in the Community of Madrid. According to the region's contracting portal, the British company has won the public contract as it is the only laboratory whose vaccine can be marketed in Spain." ["url"]=> string(120) "https://www.eleconomista.es/salud/noticias/12411204/08/23/gsk-se-lleva-el-contrato-de-vacunas-para-herpes-de-la-cam.html" ["image_url"]=> NULL ["source"]=> string(15) "eleconomista.es" ["publication_date"]=> string(10) "2023-08-18" ["categories"]=> array(5) { [0]=> string(17) "Business Disputes" [1]=> string(15) "Deals & Tenders" [2]=> string(21) "Government Connection" [3]=> string(11) "Nationalism" [4]=> string(5) "Award" } } [2]=> array(7) { ["title_en"]=> string(64) "Pandemic preparedness: GSK enters agreement with 12 EU countries" ["snippet_en"]=> string(136) "GlaxoSmithKline (GSK) has signed an agreement to reserve, produce, and supply its influenza vaccine Adjupanrix to 12 European countries." ["url"]=> string(106) "https://www.bioprocessintl.com/deal-making/pandemic-preparedness-gsk-enters-agreement-with-12-eu-countries" ["image_url"]=> string(78) "https://images.businessradar.com/articles/57176b60-0ae2-4702-aeed-97a90433ab1d" ["source"]=> string(18) "bioprocessintl.com" ["publication_date"]=> string(10) "2022-08-02" ["categories"]=> array(4) { [0]=> string(22) "EU Political Evolution" [1]=> string(8) "Epidemic" [2]=> string(15) "Deals & Tenders" [3]=> string(13) "Collaboration" } } [3]=> array(7) { ["title_en"]=> string(48) "Bilfinger receives maintenance contract from GSK" ["snippet_en"]=> string(266) "The industrial service provider Bilfinger has received a project and maintenance contract for the production facilities in Montrose, Scotland, from the pharmaceutical company Glaxosmithkline (GSK). The three-year contract is worth the equivalent of 15 million euros." ["url"]=> string(104) "https://www.pharma-food.de/utilities-services/bilfinger-erhaelt-instandhaltungs-auftrag-von-gsk-104.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/356ba01f-4726-4512-93bd-c3e37b7b29d1" ["source"]=> string(14) "pharma-food.de" ["publication_date"]=> string(10) "2021-09-13" ["categories"]=> array(5) { [0]=> string(15) "Deals & Tenders" [1]=> string(20) "Business Development" [2]=> string(20) "Contract negotiation" [3]=> string(23) "Supply Chain Management" [4]=> string(17) "Production Issues" } } [4]=> array(7) { ["title_en"]=> string(54) "Coronavirus vaccine: UK signs deal with GSK and Sanofi" ["snippet_en"]=> string(100) "The government signs a fourth deal, securing doses of a treatment being developed by GSK and Sanofi." ["url"]=> string(42) "https://www.bbc.com/news/business-53577637" ["image_url"]=> string(78) "https://images.businessradar.com/articles/bd236027-b00e-41e9-8b4d-3fadbe9f0bfb" ["source"]=> string(7) "bbc.com" ["publication_date"]=> string(10) "2020-07-29" ["categories"]=> array(3) { [0]=> string(8) "Epidemic" [1]=> string(15) "Deals & Tenders" [2]=> string(24) "Government Interventions" } } [5]=> array(7) { ["title_en"]=> string(82) "SpeeDx Announces Collaboration Agreement with GSK to Supply Testing and Technology" ["snippet_en"]=> string(146) "SpeeDx Pty. Ltd., a developer of innovative solutions for molecular diagnostics, has entered into a collaboration agreement with GSK. Under this V" ["url"]=> string(57) "https://www.businesswire.com/news/home/20190624005452/de/" ["image_url"]=> NULL ["source"]=> string(16) "businesswire.com" ["publication_date"]=> string(10) "2019-06-24" ["categories"]=> array(3) { [0]=> string(23) "Supply Chain Management" [1]=> string(15) "Deals & Tenders" [2]=> string(13) "Collaboration" } } [6]=> array(7) { ["title_en"]=> string(99) "Santaris Pharma A/S announce agreement with GlaxoSmithKline (GSK) to develop RNA-targeted medicines" ["snippet_en"]=> string(159) "/PRNewswire/ -- Santaris Pharma A/S has announced today that they have signed an agreement with GlaxoSmithKline (GSK), whereby, pursuant to an option right,..." ["url"]=> string(152) "https://www.prnewswire.com/news-releases/santaris-pharma-as-announce-agreement-with-glaxosmithkline-gsk-to-develop-rna-targeted-medicines-239595851.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/e78a986d-6f8f-4d7e-8abc-0ebe137d50aa" ["source"]=> string(14) "prnewswire.com" ["publication_date"]=> string(10) "2014-01-10" ["categories"]=> array(3) { [0]=> string(14) "Product Launch" [1]=> string(15) "Deals & Tenders" [2]=> string(13) "Collaboration" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(28) } [1]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(26) } [2]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(26) } [3]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(21) } [4]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(20) } [5]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(18) } [6]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(17) } [7]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(16) } [8]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(15) } [9]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(14) } [10]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(14) } [11]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(13) } [12]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(12) } [13]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(11) } [14]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(10) } [15]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(10) } [16]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(9) } [17]=> array(2) { ["name"]=> string(20) "Business Development" ["count"]=> int(9) } [18]=> array(2) { ["name"]=> string(13) "Data Security" ["count"]=> int(8) } [19]=> array(2) { ["name"]=> string(16) "Customer Welfare" ["count"]=> int(7) } [20]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(7) } [21]=> array(2) { ["name"]=> string(19) "Economic Conditions" ["count"]=> int(6) } [22]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(6) } [23]=> array(2) { ["name"]=> string(6) "Crisis" ["count"]=> int(6) } [24]=> array(2) { ["name"]=> string(21) "Cultural developments" ["count"]=> int(6) } [25]=> array(2) { ["name"]=> string(7) "Layoffs" ["count"]=> int(6) } [26]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(6) } [27]=> array(2) { ["name"]=> string(24) "Employee Health & Safety" ["count"]=> int(6) } [28]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(5) } [29]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(5) } } } 4abba-us-gsk-consumer-health-inc

Gsk Consumer Health, Inc.

Location

New Jersey

Founded

1994-02-28

Website

https://www.gsk.com

Articles

450 Articles

Category

Pharmaceutical Preparations

Description

GSK Consumer Healthcare is a global business that discovers, develops, and manufactures innovative consumer healthcare products. It is an associate of GlaxoSmithKline plc, one of the world's largest healthcare companies. GSK Consumer Healthcare aims to become one of the world's most innovative, best performing, and trusted healthcare companies. Their goal is to improve lives through scientific innovation, build category-defining brands, and become Pakistan's first and best Fast Moving Consumer Healthcare Company.

Articles

Business life - In La Chapelle-d'Angillon, 3C France benefits from investments in the pharmaceutical industry

2024-03-06 (leberry.fr)

Business life - In La Chapelle-d'Angillon, 3C France benefits from investments in the pharmaceutical industry

In a booming pharmaceutical sector, the family business 3C France has won a big deal with the British giant GSK which is investing in France.

Read more
GSK wins CAM herpes vaccine contract

2023-08-18 (eleconomista.es)

GSK wins CAM herpes vaccine contract

The pharmaceutical company GSK will be the sole supplier of the shingles vaccine in the Community of Madrid. According to the region's contracting portal, the British company has won the public contract as it is the only laboratory whose vaccine can be marketed in Spain.

Read more
Pandemic preparedness: GSK enters agreement with 12 EU countries

2022-08-02 (bioprocessintl.com)

Pandemic preparedness: GSK enters agreement with 12 EU countries

GlaxoSmithKline (GSK) has signed an agreement to reserve, produce, and supply its influenza vaccine Adjupanrix to 12 European countries.

Read more
Bilfinger receives maintenance contract from GSK

2021-09-13 (pharma-food.de)

Bilfinger receives maintenance contract from GSK

The industrial service provider Bilfinger has received a project and maintenance contract for the production facilities in Montrose, Scotland, from the pharmaceutical company Glaxosmithkline (GSK). The three-year contract is worth the equivalent of 15 million euros.

Read more
Coronavirus vaccine: UK signs deal with GSK and Sanofi

2020-07-29 (bbc.com)

Coronavirus vaccine: UK signs deal with GSK and Sanofi

The government signs a fourth deal, securing doses of a treatment being developed by GSK and Sanofi.

Read more
SpeeDx Announces Collaboration Agreement with GSK to Supply Testing and Technology

2019-06-24 (businesswire.com)

SpeeDx Announces Collaboration Agreement with GSK to Supply Testing and Technology

SpeeDx Pty. Ltd., a developer of innovative solutions for molecular diagnostics, has entered into a collaboration agreement with GSK. Under this V

Read more
Santaris Pharma A/S announce agreement with GlaxoSmithKline (GSK) to develop RNA-targeted medicines

2014-01-10 (prnewswire.com)

Santaris Pharma A/S announce agreement with GlaxoSmithKline (GSK) to develop RNA-targeted medicines

/PRNewswire/ -- Santaris Pharma A/S has announced today that they have signed an agreement with GlaxoSmithKline (GSK), whereby, pursuant to an option right,...

Read more

Newsletter subscription